glp-1 rheumatoid arthritis study Glucagon-Like Peptide-1 (GLP-1) receptor agonists in rheumatology: A review of current evidence and future directions GLP-1 receptor agonists in rheumatic

OTHERS Recent investigations have elucidated a multifaceted spectrum of adverse effects linked to GLP-1 RAs (Table 1), necessitating meticulous interpretation based on the various methodological designs employed, including RCTs and retrospective analyses

Are natural GLP-1s safe

Conversely, a retrospective study with 981 patients with T2DM showed no difference in diabetic retinopathy progression between GLP-1 RAs and SGLT-2 inhibitors [94]

Not Sure How Your Metabolism Is Working

Elsharkawy, Alexandria Main University Hospitals, Alexandria, Egypt Mohamed El-Samahy, Faculty of Medicine, Zagazig University, Sharkia, Egypt

Therefore, researchers are working toward developing formulations that can be administered once a week, providing a longer-lasting effect and reducing the frequency of injections